Search company, investor...

Predict your next investment

Investments

3

Portfolio Exits

1

About Erasmus Advisors

Headquarters Location

Want to inform investors similar to Erasmus Advisors about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Erasmus Advisors Investments

3 Investments

Erasmus Advisors has made 3 investments. Their latest investment was in MedServe as part of their Unattributed VC - II on October 10, 2006.

CBI Logo

Erasmus Advisors Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/13/2006

Unattributed VC - II

MedServe

$70M

No

9/9/2005

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

0

10/18/2004

Series B

Subscribe to see more

$99M

Subscribe to see more

0

Date

10/13/2006

9/9/2005

10/18/2004

Round

Unattributed VC - II

Unattributed VC

Series B

Company

MedServe

Subscribe to see more

Subscribe to see more

Amount

$70M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

Erasmus Advisors Portfolio Exits

1 Portfolio Exit

Erasmus Advisors has 1 portfolio exit. Their latest portfolio exit was MedServe on May 14, 2009.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/14/2009

Acquired

$99M

1

Date

5/14/2009

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.